Ratings Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Real-time Estimate Cboe BZX 10:31:11 29/04/2024 pm IST 5-day change 1st Jan Change
17.44 USD +0.49% Intraday chart for Crescent Capital BDC, Inc. +1.63% +0.40%

Strengths

  • The group's activity appears highly profitable thanks to its outperforming net margins.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Over the last twelve months, the sales forecast has been frequently revised upwards.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
  • Considering the small differences between the analysts' various estimates, the group's business visibility is good.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • The group usually releases upbeat results with huge surprise rates.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • The company's earnings growth outlook lacks momentum and is a weakness.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Closed End Funds

1st Jan change Capi. Investor Rating ESG Refinitiv
+0.40% 643M -
+4.22% 12.61B
C
+6.57% 9.01B -
C-
-3.61% 5.41B
D+
+2.87% 5.25B -
D
+5.74% 5.19B - -
+14.91% 4.48B - -
+16.71% 4.44B - -
+1.53% 4B -
+3.73% 3.75B -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. Ratings Crescent Capital BDC, Inc.